Search bioRxiv⌕ Search

Biology subjects

Abou-Kheir, W.

Publications and source records attributed to Abou-Kheir, W..

2 recordsLinked to original sources

Frequency-Dependent Modulation of Adult Hippocampal Neurogenesis, Memory, and BDNF Signaling by Low-Intensity Focused Ultrasound

Adult hippocampal neurogenesis plays a central role in learning, memory formation, and adaptive neural plasticity, making it an attractive target for noninvasive neuromodulation strategies. Low-intensity focused ultrasound (LIFU) has emerged as a promising modality for modulating brain function, yet its effects on adult neurogenesis and the role of stimulation frequency remain incompletely understood. In this study, we evaluated whether transcranial LIFU applied to the dentate gyrus influences neurogenic and cognitive outcomes in a frequency-dependent manner. Adult rats received twice-weekly ultrasound stimulation for four weeks at 0.5, 1, or 5 MHz. Neurogenesis was assessed through BrdU incorporation and neuronal differentiation by BrdU/NeuN co-labeling, while expression of neurogenesis-associated markers (BDNF, FGF-2, and Sox-2) was quantified using qRT-PCR. Behavioral effects were examined using the novel object recognition task. Among the tested conditions, 0.5 MHz stimulation produced the most pronounced neurogenic response, with increased cellular proliferation in the dentate gyrus, elevated expression of neurogenic markers, and improved recognition memory relative to sham-treated animals. Higher stimulation frequencies yielded comparatively weaker effects. These findings identify stimulation frequency as a critical determinant of LIFU-driven neuroplastic responses and support the potential of focused ultrasound as a noninvasive approach for promoting hippocampal regeneration and functional recovery.

bioengineering↗

Specific Inhibition of GSK-3β by Tideglusib: Potential Therapeutic Target for Neuroblastoma Cancer Stem Cells

Neuroblastoma is an embryonic tumor that represents the most common extracranial solid tumor in children. Resistance to therapy is attributed, in part, to the persistence of a subpopulation of slowly dividing cancer stem cells (CSCs) within those tumors. Glycogen synthase kinase (GSK)-3{beta} is an active proline-directed serine/threonine kinase, well-known to be involved in different signaling pathways entangled in the pathophysiology of neuroblastoma. This study aims to assess the potency of an irreversible GSK-3{beta} inhibitor drug, Tideglusib (TDG), in suppressing proliferation, viability, and migration of human neuroblastoma cell lines, as well as its effects on their CSCs subpopulation in vitro and in vivo. Our results showed that treatment with TDG significantly reduced cell proliferation, viability, and migration of SK-N-SH and SH-SY5Y cells. TDG also significantly inhibited neurospheres formation capability in both cell lines, eradicating the self-renewal ability of highly resistant CSCs. Importantly, TDG potently inhibited neuroblastoma tumor growth and progression in vivo. In conclusion, TDG proved to be an effective in vitro and in vivo treatment for neuroblastoma cell lines and may hence serve as a potential adjuvant therapeutic agent for this aggressive nervous system tumor.

cancer biology↗